UK
USA
Canada
IntelliRisk™ enables healthcare providers to assess, identify, and manage high risk patients efficiently and effectively. By incorporating established clinical guidelines, advanced short-term and long-term breast cancer risk models, and best practices, it supports informed decision-making across the entire breast health pathway.
Provides precise, individualised life-time breast cancer risk assessments, supporting treatment plans that are tailored to each patient’s unique risk profile.
Streamlined data integration enables rapid access to comprehensive risk insights, allowing for faster, more coordinated decision-making in patient management.
Supports healthcare providers in meeting clinical guidelines by offering a structured approach to identify, monitor, and document high-risk patients, aligning with national standards for cancer care.
Prioritises proactive management of high-risk patients to optimise resource allocation, contributing to sustainable practices that focus on prevention and targeted surveillance over time.
Healthcare leaders across the spectrum – service line managers, CMOs, CIOs, large health systems, Integrated Delivery Network, and private radiology groups – are increasingly recognising the pivotal role of high-risk breast cancer clinics. Once considered a niche concept, these specialised programs are quickly becoming a standard component of comprehensive breast care. The big question for administrators and executives is clear: How do high-risk clinics financially justify themselves while improving patient outcomes?
Densitas delivers integrated image quality assurance and risk stratification to support high-risk clinic pathways. Read our latest blog to learn more.
